Literature DB >> 11371701

Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

H Knobel1, A Guelar, G Vallecillo, X Nogués, A Díez.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11371701     DOI： 10.1097/00002030-200104130-00022

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  37 in total

1.  Bone disease in HIV infection.

Authors:  Maristella Francesca Saccomanno; Adriana Ammassari
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

2.  Bone mass and mineral metabolism in HIV+ postmenopausal women.

Authors:  Michael Yin; Jay Dobkin; Karen Brudney; Carolyn Becker; Janis L Zadel; Monica Manandhar; Vicki Addesso; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2005-03-08       Impact factor: 4.507

3.  Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.

Authors:  Denise L Jacobson; Donna Spiegelman; Tamsin K Knox; Ira B Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

4.  [Drug-induced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy].

Authors:  R Bartl; C Bartl; R Gradinger
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

5.  Longitudinal analysis of bone density in human immunodeficiency virus-infected women.

Authors:  Sara E Dolan; Jenna R Kanter; Steven Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

6.  Low bone mineral density and associated risk factors in HIV-infected patients.

Authors:  Cristina-Emilia Chiţu-Tișu; Ecaterina-Constanţa Barbu; Mihai Lazăr; Daniela Adriana Ion; Ioana Anca Bădărău
Journal:  Germs       Date:  2016-06-01

7.  Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.

Authors:  Michael T Yin; Don J McMahon; David C Ferris; Chiyuan A Zhang; Aimee Shu; Ronald Staron; Ivelisse Colon; Jeffrey Laurence; Jay F Dobkin; Scott M Hammer; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

8.  Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.

Authors:  J M Fakruddin; J Laurence
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis.

Authors:  Jeannie Huang; Linda Meixner; Susan Fernandez; J Allen McCutchan
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

10.  Impact of age on markers of HIV-1 disease.

Authors:  Vanessa Pirrone; David J Libon; Christian Sell; Chad A Lerner; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.